Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB
-
* Corresponding author: Xiao-Shi Zhang zxs617@hotmail.com
Journal of Translational Medicine 2009, 7:56 doi:10.1186/1479-5876-7-56
Accesses
- Last 30 days: 109 accesses
- Last 365 days: 951 accesses
- All time: 2867 accesses
Cited by
BioMed Central: 1 citation
|
Po Zhao, Yazhuo Li, Yali Lu BMC Cancer 2010, 10:218 (20 May 2010) |